| Document Date: 2014-05-30 11:29:54 Open Document File Size: 273,37 KBShare Result on Facebook
City Memphis / Portland / Tucson / Overall / Boston / Chicago / Waltham / / Company 3TESARO Inc. / US Oncology / AEs / Subjects / / Continent America / / Country United States / / Event FDA Phase / / Facility Clinical Research Center / Tufts Medical Center / Tennessee Health Sciences Center / / IndustryTerm control groups / rolapitant / control / prevention of CINV in cancer / / MedicalCondition tumor / cancer / Chemotherapy-Induced Nausea / nausea/vomiting / nausea / Vomiting / vomiting domain / Breast cancer / significant nausea / / MedicalTreatment Chemotherapy / / Organization Medical Center / 2Arizona Clinical Research Center / Tennessee Health Sciences Center / / Product granisetron / Carboplatin / dexamethasone / cytarabine / cyclophosphamide / ifosfamide / Rescue Medication / rolapitant / / ProvinceOrState Tennessee / Illinois / Oregon / Arizona / Massachusetts / / Region South Africa / / Technology Chemotherapy / /
SocialTag |